BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8394089)

  • 1. A longitudinal prospective study of cytomegalovirus pp65 antigenemia in renal transplant recipients.
    Bein G; Bitsch A; Hoyer J; Steinhoff J; Fricke L; Machnik H; Dennin R; Kirchner H
    Transpl Int; 1993; 6(4):185-90. PubMed ID: 8394089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients.
    Wirgart BZ; Claesson K; Eriksson BM; Brundin M; Tufveson G; Tötterman T; Grillner L
    Clin Diagn Virol; 1996 Nov; 7(2):99-110. PubMed ID: 9137866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of human cytomegalovirus infections in heart transplant recipients by pp65 antigenemia.
    Sénéchal M; Dorent R; du Montcel ST; Fillet AM; Ghossoub JJ; Dubois M; Pavie A; Gandjbakhch I
    Clin Transplant; 2003 Oct; 17(5):423-7. PubMed ID: 14703924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shell-vial culture and pp65 antigenemia assay in the detection of cytomegalovirus in the first blood sample of renal transplant recipients.
    Reina J; Fernandez-Baca V; Saurina J; Blanco I; Munar M
    J Med Virol; 1998 Jul; 55(3):240-2. PubMed ID: 9624613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
    Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
    Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenemia, immunoblotting, and enzyme immunoassay for early diagnosis of cytomegalovirus infection in renal transplant patients.
    Fischer L; Rautenberg P; Bienengräber H; Leimenstoll G
    Transpl Int; 1993; 6(4):201-5. PubMed ID: 8394090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the CMV antigenemia test and CMV-DNA PCR results in solid organ transplant recipients].
    Özkarata E; Özbek ÖA; Avkan Oğuz V; Sayıner AA
    Mikrobiyol Bul; 2016 Jan; 50(1):44-52. PubMed ID: 27058328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early diagnosis of CMV infection by detection of pp65 antigen in 91 renal transplant recipients.
    Lamy ME; Mulongo NK; Vargas M; Pirson Y; Squifflet JP
    Transpl Int; 1994 Jul; 7(4):237-42. PubMed ID: 7916921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential cytomegalovirus antigenemia monitoring in kidney transplant patients treated with antilymphocyte antibodies.
    Ozaki KS; Pestana JO; Granato CF; Pacheco-Silva A; Camargo LF
    Transpl Infect Dis; 2004 Jun; 6(2):63-8. PubMed ID: 15522106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Murex Hybrid Capture CMV DNA (v2.0) assay and the pp65 CMV antigenemia test for the detection and quantitation of CMV in blood samples from immunocompromised patients.
    Schirm J; Kooistra A; van Son WJ; van der Bij W; Verschuuren E; Sprenger HG; Limburg PC; The TH
    J Clin Virol; 1999 Dec; 14(3):153-65. PubMed ID: 10614852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients.
    Storch GA; Buller RS; Bailey TC; Ettinger NA; Langlois T; Gaudreault-Keener M; Welby PL
    J Clin Microbiol; 1994 Apr; 32(4):997-1003. PubMed ID: 8027357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
    Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
    Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
    J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ethylenediaminetetraacetic acid and sodium citrate as anticoagulants in collection of samples for cytomegalovirus pp65 antigen detection in renal transplant recipients with suspected cytomegalovirus disease.
    Patnaik N; Ratho RK; Mishra B; Chakraborty A; Sakhuja VK
    J Virol Methods; 2008 Feb; 147(2):319-21. PubMed ID: 17996957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a novel immunoglobulin A capture enzyme immunoassay for diagnosis of cytomegalovirus infection in renal and heart transplant recipients.
    Rautenberg P; Fischer L; Tönnies R; Franke D
    Eur J Clin Microbiol Infect Dis; 1997 Sep; 16(9):653-9. PubMed ID: 9352258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid immunocytochemical assay for CMV detection in peripheral blood of organ-transplanted patients in clinical practice.
    Halwachs G; Zach R; Pogglitsch H; Holzer H; Tiran A; Iberer F; Wasler A; Tscheliessnigg HP; Lanzer G; Fölsch B
    Transplantation; 1993 Aug; 56(2):338-42. PubMed ID: 8395099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.
    Schvoerer E; Henriot S; Zachary P; Freitag R; Fuchs A; Fritsch S; Risch S; Meyer N; Caillard S; Lioure B; Stoll-Keller F
    J Med Virol; 2005 May; 76(1):76-81. PubMed ID: 15778970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of plasma polymerase chain reaction and pp65-antigenemia assay in the quantification of cytomegalovirus in liver and kidney transplant patients.
    Piiparinen H; Höckerstedt K; Grönhagen-Riska C; Lappalainen M; Suni J; Lautenschlager I
    J Clin Virol; 2001 Aug; 22(1):111-6. PubMed ID: 11418358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.